August 24, 2026

argenx SE (ARGX) Stock Analysis: Unpacking the 12.79% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a trailblazer in the biotechnology sector, is capturing investor attention with its promising therapeutic pipeline and robust market performance. Based in the Netherlands and operating globally,..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 9.41% Potential Upside Amid Healthcare Growth

Universal Health Services, Inc. (NYSE: UHS) stands as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $10.45..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 29.47% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands prominently in the healthcare sector as a leader among specialty and generic drug manufacturers. With a market capitalization of $22.01 billion, this biotech giant..

West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence

West Pharmaceutical Services, Inc. (NYSE: WST) continues to capture investor attention with its solid positioning in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Summit Therapeutics Inc. (SMMT): Growth Potential and Analyst Consensus with 117.45% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy player in the biotechnology sector, specializing in the discovery and development of innovative therapies aimed at addressing unmet medical needs. With..

Penumbra, Inc. (PEN) Stock Analysis: Exploring Growth Potential and Market Position

Penumbra, Inc. (PEN), a prominent player in the healthcare sector, continues to capture investor attention with its innovative medical devices. Based in Alameda, California, Penumbra designs, develops, manufactures, and markets..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 10.46% Upside Potential Awaits Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) has been capturing attention in the healthcare sector with its solid performance and promising growth outlook. The company, established in 1987 and headquartered in..

BridgeBio Pharma (BBIO) Stock Analysis: Strong Buy Ratings and 33% Potential Upside Captivate Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a key player in the biotechnology sector, has been making waves with its robust pipeline of therapies aimed at genetic diseases. Founded in 2015 and..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 28% Potential Upside with Innovative Biotech Solutions

For investors seeking opportunities in the biotechnology sector, TG Therapeutics, Inc. (NASDAQ: TGTX) presents an intriguing case with its robust market performance and promising pipeline. With a current market cap..

Molina Healthcare Inc (MOH) Stock Analysis: A Mixed Outlook with Modest Upside Potential

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, presents a complex investment scenario for individual investors seeking exposure in the healthcare sector. With a market..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 10.87% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the healthcare sector, specifically in drug manufacturing, continues to capture investor attention with its strong presence in the global pharmaceutical..

STERIS plc (STE) Stock Analysis: Exploring a 10.59% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find the current profile of STERIS plc (NYSE: STE) particularly intriguing. With a market capitalization of $23.2 billion, STERIS stands as a..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Leader’s Potential Amid Market Volatility

Tempus AI, Inc. (TEM) is carving a niche in the healthcare technology sector with its pioneering integration of advanced analytics and diagnostic services. Headquartered in Chicago, Illinois, this U.S.-based company..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 23.63% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology industry, capturing investor attention with its impressive growth metrics and robust pipeline of therapeutics. Based in Hellerup, Denmark, this..

The Cooper Companies, Inc. (COO) Stock Analysis: Strong Buy Ratings with 6.93% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in San Ramon, California, the company has..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Healthcare with a Strategic Edge

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its diverse portfolio of medical instruments and supplies. Headquartered in Franklin Lakes,..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 74% Potential Upside in the Vaccine Innovation Leader

Vaxcyte, Inc. (NASDAQ: PCVX), headquartered in San Carlos, California, is garnering significant attention in the biotechnology sector, largely due to its innovative approach to vaccine development. With a market capitalization..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, continues to capture investor interest with its robust portfolio..

DaVita Inc. (DVA) Stock Analysis: Potential 25.66% Upside for Healthcare Investors

DaVita Inc. (DVA) stands as a prominent player in the healthcare sector, specializing in medical care facilities with a focus on kidney dialysis services. Headquartered in Denver, Colorado, and operating..

Danaher Corporation (DHR) Investor Outlook: Strong Buy Ratings and Growth in Healthcare

Danaher Corporation (NYSE: DHR), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has captured investor attention with its robust market presence and promising growth..

Search

Funds

August 24, 2026

Search

Funds

August 24, 2026

FTSE 100

Funds